Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

I think the intention of the poster before you was to highlight that monoclonal antibodies (likely) actually make more money for big pharma than a course of vaccination. A lot of anti-vaccine rhetoric revolves around vaccines being a big pharma cash grab.

For context, each dose of most of the covid vaccines is about $40 while a round of monocolonal antibody treatment is around $1,500. The vaccine has a dramatic effect in limiting the affects of covid and (as far as I a non-doctor know) stack with monoclonal antibodies if needed. Its just dramatically cheaper if people are vaccinated and not as many people need this treatment.



Addressable market for vaccines is larger than treatments: all population vs. those get sick

Also vaccines as those we have today are recurrent revenue: one shot every 6 / 12 months?




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: